Scarica il programma

(1)

17^th MEET THE PROFESSOR

Advanced International Breast Cancer Course (AIBCC)

For information www.accmed.org

(2)

Mortality from breast cancer is declining in most countries thanks to effective screening programs, early diagnosis, molecular characterization of the different subtypes and biology-driven treatments. A multidisciplinary management of breast cancer patients is therefore the key to success and a breast multidisciplinary team should include - besides the “classic” clinical specialties - pathologists, molecular biologists and geneticists. Furthermore, the availability of multiple diagnostic and therapeutic choices, the increasing costs of new technologies and drugs and the issue of sustainability represent a new challenge for socially- responsible clinicians. With this goal in mind, the Programme includes lectures on molecular characterization, updated treatments of early and advanced disease, management of difficult cases and hereditary syndromes and issues of sustainability and drug access across countries.

Aims

Gynaecologists and obstetrics, medical oncologists, pathologists, radiologists, radiation oncologists, surgeons. Biologists, pharmacists, and nurses.

Addressed to

(3)

14.45 Introduction to the Conference

Pier Franco Conte, Gabriel N. Hortobagyi, Valentina Guarneri, Philip Poortmans

SESSION I

Chairpersons: Hesham Ahmed Gaballah Elghazaly, Pier Franco Conte

15.20 Obesity and cancer Roberto Vettor

15.20 Management of women BRCA1/2

and other predisposition gene mutations Shani Paluch-Shimon

15.40 Axillary dissection: still an option?

Elefterios Mamounas

16.00 Hot topics in breast cancer RT Philip Poortmans

16.20 Clinical impact of genomics in BC Aleix Prat

16.40 PIK3CA testing: from technical aspects to clinical application Sybille Loibl

17.00 Prognostic signatures to guide treatment decision Gabriel N. Hortobagyi

17.20 Q&A

17.30 Adjourn

Thursday, September 30 ^th

International speakers will be connected from various countries and local speakers will be present at the meeting venue.

(4)

Friday, October 1 ^st

SESSION II –MULTIDISCIPLINARY TUMOR BOARD Chairperson: Pier Franco Conte, Valentina Guarneri

10.00 Clinical case 1: Omission of RT in elderly patients with low-risk tumor

Franco Berti

10.20 Clinical case 2: cT1c, cN0 HER2+tumor: neo vs adjuvant (option to escalate or de-escalate therapy)

Cristina Falci

10.40 Clinical case 3: Post-neoadjuvant therapy in patients with RD (stressing the concept of RCB and characterization of RD) Federica Miglietta

11.00 Clinical case 4: oligometastatic disease Grazia Vernaci

11.20 Clinical case 5: Brain mets Gaia Griguolo

11.40 Clinical case 6: when to stop active therapy Carlo Alberto Giorgi

12.00 Lunch SESSION III

Chairpersons: Jacek Jassem, Valentina Guarneri

14.30 Adjuvant CDK4/6i for HR+ disease:

reconciling data from randomized trials Valentina Guarneri

International speakers will be connected from various countries and local speakers will be present at the meeting venue.

(5)

14.50 Early BRCAm tumors: PARPi are coming!

Pier Franco Conte

15.10 Neoadjuvant therapy for early breast cancer:

beyond the pCR dogma Pier Franco Conte

15.30 Immunotherapy for early TNBC: hopes and hypes Hope Rugo

15.50 Q&A

16.10 Antibody Drug Conjugates for BC Frederik Marmè

16.30 Targeting unconventional pathways in Luminal BC Maria Vittoria Dieci

16.50 Treatment algorithm for HR+/HER2- ABC Stephen Johnston

17.10 Treatment algorithm for HER2+ ABC Sandra Swain

17.30 Treatment algorithm and new options for TN ABC Miguel Martin

17.50 Q&A

18.10 Adjourn

(6)

Access Mode

To ensure compliance with the health event provisions relating to Covid-19, AIBCC 2021 will be held both as in-class course and as a live webinar.

When registering, it is necessary to select the desired participation method, until exhaustion of available places. Registration for the activity can only take place online, no registrations will be accepted at the congress venue.

AccMed reserves the right to carry out the event exclusively in digital mode if the situation of the health emergency from Covid-19 makes it necessary. In this case, AccMed will be responsible for informing speakers and participants of the change in the way the event is going to be held.

Live webinar

The Live Webinar will allow participants to attend to AIBCC 2021 from anywhere in the world.

The Live Webinar, with the participation of speakers connected from various countries, is addressed to both Italian and foreign participants. The official language of the course is English. No simultaneous translation will be provided.

To follow the webinar, participants will need a good quality internet connection and a device (PC, Smartphone, Tablet) capable of running a recent Internet browser (e.g. any updated version of Chrome or Firefox).

In-Class Course

The in-class course will take place at the venue specified underneath. Please note that due to COVID mitigation measures, the availability of places for the in-presence course is limited.

The in-class course, with the participation of speakers connected from various countries and local speakers present at the meeting venue, is addressed primarily to Italian participants. The official language of the course is English.

No simultaneous translation will be provided.

(7)

CME Webinar live

Based on the in force regulations approved by the CNFC, Accademia Nazionale di Medicina (provider n. 31) will assign to the activity CME (31-324301): 12 CME points.

Training objective: professional and technical content (knowledge and skills) specific to each profession, specialisation and highly specialised activity. Rare disease.

The credit certification for the webinar is subject to:

- Professions/specializations should correspond to those which have been accredited for CME

- attendance at the 100% of the async distance learning and webinar live on the platform fad.accmed.org;

- the completion of the Meeting evaluation online form;

- completion of the final test (at least 75% of correct answers). 5 attempts admitted.

The test and the meeting evaluation form must be completed within 3 days from the end of the event.

CME In-Class Course

Based on the in force regulations approved by the CNFC, Accademia Nazionale di Medicina (provider n. 31) will assign to the activity CME (31-324769): 8 CME points.

The credit certification for the webinar is subject to:

- Professions/specializations should correspond to those which have been accredited for CME;

- attendance at the 90% of the meeting;

- completion of the meeting evaluation online form;

- completion of the final test (at least 75% of correct answers).

1 attempt admitted.

The test and the meeting evaluation form must be completed within 3 days from the end of the event.

Training objective: professional and technical content (knowledge and skills) specific to each profession, specialisation and highly specialised activity. Rare disease.

(8)

Scientific Committee

Hesham Ahmed Gaballah Elghazaly Department of Clinical Oncology and nuclear medicine

University of Ainshams Cairo (EG)

Jacek Jassem

Department of Oncology and Radiotherapy Medical University of Gdansk (PL)

Stephen Johnston

NIHR Biomedical Research Centre for Cancer Royal Marsden NHS Foundation

Trust & Institute of Cancer Research London (UK)

Sibylle Loibl

German Breast Group University of Frankfurt (D) Eleuterios Mamounas Comprehensive Breast Program MD Anderson Cancer Center Orlando Orlando (F)

Miguel Martin

Medical Oncology Service

Hospital Universitario Gregorio Marañon Madrid (E)

Stefania Migliuolo Europa Donna Italia Milan (I)

Fedro Alessandro Peccatori Department of Medical Oncology European Institute of Oncology (IEO) Milan (I)

Aleix Prat

Medical Oncology Department Hospital Clinic

Barcellona (E) Sandra M. Swain Research Development

Georgetown University Medical Center Washington (USA)

Directors

Pier Franco Conte

Division of Medical Oncology 2 Istituto Oncologico Veneto IRCCS Department of Surgery, Oncology and Gastroenterology

University of Padova (I) Valentina Guarneri

University of Padova (I)

Gabriel N. Hortobagyi

Department of Breast Medical Oncology The University of Texas -

MD Anderson Cancer Center Houston (USA)

Philip Poortmans

Former president of ESTRO and of ECCO Department of Radiation Oncology Iridium Netwerk

University of Antwerp Wilrijk-Antwerp (B)

(9)

Speakers

Franco Berti

Department of Radiation Oncology Istituto Oncologico Veneto IRCCS Department of Surgery, Oncology and Gastroenterology

University of Padua (I) Pier Franco Conte

University of Padova (I) Maria Vittoria Dieci

University of Padova (I) Cristina Falci

University of Padua (I) Carlo Alberto Giorgi

University of Padua (I) Gaia Griguolo

University of Padua (I)

Valentina Guarneri

University of Padova (I) Gabriel N. Hortobagyi

Department of Breast Medical Oncology The University of Texas -

MD Anderson Cancer Center Houston (USA)

Stephen Johnston

NIHR Biomedical Research Centre for Cancer Royal Marsden NHS Foundation Trust &

Institute of Cancer Research London (UK)

Sibylle Loibl

German Breast Group University of Frankfurt (D) Eleuterios Mamounas Comprehensive Breast Program MD Anderson Cancer Center Orlando Orlando (F)

Frederik Marmè

National Center for Tumor Diseases (NCT) University of Heidelberg (DE)

Miguel Martin

Medical Oncology Service

Hospital Universitario Gregorio Marañon Madrid (E)

Federica Miglietta

University of Padua (I)

(10)

Shani Paluch-Shimon Sharett Institute of Oncology Hadassah University Hospital Jerusalem (IL)

Philip Poortmans

Former president of ESTRO and of ECCO Department of Radiation Oncology Iridium Netwerk

University of Antwerp Wilrijk-Antwerp (B) Aleix Prat

Medical Oncology Department Hospital Clinic

Barcellona (E) Hope Rugo

UCSF Carol Franc Buck Breast Care Center Breast Oncology Clinical Trials Program San Francisco (USA)

Sandra M. Swain Research Development

Georgetown University Medical Center Washington (USA)

Grazia Vernaci

University of Padua (I) Roberto Vettor

Division of Internal Medicine University of Padova (I)

(11)

€ 180,00

€ 100,00 for graduate students and nurses

Online registration at http://meettheprofessor.accmed.org before 20 September;

the application will be completed only after the payment of the registration fee.

CANCELLATION

In order to cancel please give advise with a written communication to Accademia Nazionale di Medicina within 10 days from the beginning. A 70% of the registration fee will be returned. Any cancellation after that deadline will not be reimbursed.

Registration

Un’azione sostenibile a favore della formazione Iscrizione gratuita UNDER 40 ﬁno a esaurimento posti

Free admission is available for a few people “under 40”.

Registration forms will be accepted on a first-come, first-served basis until spaces will be full.

The Organization Secretariat will confirm the registration by email.

Under 40

Meeting venue In-Class Course

Four Points by Sheraton Corso Argentina, 5 Padova

(12)

Supported by unrestricted educational grants from

GOLD SPONSOR

BRONZE SPONSOR SILVER SPONSOR

CONTRIBUTORS

(13)

With the patronage of

INSTITUTIONS

SCIENTIFIC SOCIETIES

Comune di Padova

(14)

Organizer ACCADEMIA NAZIONALE

DI MEDICINA

General Manager: Stefania Ledda www.accmed.org Information:

http://meettheprofessor.accmed.org Ph. 0039 51 0569163 – 51 6360080 info.bologna@accmed.org

Organizing Partner Forum Service Via Martin Piaggio, 17/8 16122 Genova